|
18/JAN/13
Neuron BioPharma attends the JP Morgan Investors Healthcare Conference
The pharmaceutical division of Neuron Bio, Neuron BioPharma, met with various investment organizations and large pharmaceutical companies at the JP Morgan Healthcare Conference, which took place from 7 to 10 January 2013 in San Francisco, USA.
During the four days, the CSO of Neuron BioPharma Dr. Javier S. Burgos, had several meetings with potential investors interested in both the discovery platform of the company and its product portfolio amongst which the compound NST0037, a drug designed for the treatment of Alzheimer’s disease, stood out.
The JP Morgan Healthcare Conference, organized annually in San Francisco by the JP Morgan finance company, attracts the most important investors in the life-sciences sector from all over the world. This year there were more than 10,000 participants, including executives from biotechnology and pharmaceutical companies and investors specializing in health-sciences.
|